0001628280-20-005205.txt : 20200421 0001628280-20-005205.hdr.sgml : 20200421 20200421171753 ACCESSION NUMBER: 0001628280-20-005205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200417 FILED AS OF DATE: 20200421 DATE AS OF CHANGE: 20200421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eltoukhy Helmy CENTRAL INDEX KEY: 0001752968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 20805961 MAIL ADDRESS: STREET 1: 2 BARRY LANE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_158750385593612.xml FORM 4 X0306 4 2020-04-17 0 0001576280 Guardant Health, Inc. GH 0001752968 Eltoukhy Helmy 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chief Executive Officer COMMON STOCK 2020-04-17 4 S 0 15804 70.2112 D 3175080 D COMMON STOCK 2020-04-17 4 S 0 100 71.2102 D 3174980 D COMMON STOCK 119550 I Shares held by Helmy A. Eltoukhy Revocable Trust COMMON STOCK 664020 I Shares held by Eltoukhy Investments, L.P. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $70.00 to $70.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $71.04 to $71.245, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Michael Wiley, as Attorney-in-Fact for Helmy Eltoukhy 2020-04-21